Log inCreate free account
YOUR DAILY WORKSPACE
The market. In focus.
Market briefing · 2026-09-30
01

Mortgage rates jump for sixth straight week, hitting demand

YOUR WATCHLISTNVDA PLTR AMD
See the workspace
THE COMPANY VIEW
NVDA · Weekly focus
Reviewed Sep 25, 2026

Upward momentum20-session lookback · through Sep 24, 2026

Q2 FY2027 revenue $96.2B, up 106% year over year

See the workspace

AI-Powered Research for
Better Investment Decisions

Know where your stocks stand.
Stay on top of what changes.

Follow the stocks you care about with daily market context, weekly company insights, and a timeline of news and SEC filings.

SEC filingsCompany disclosuresMarket dataNewsAbout our sources
THE THESISMEMO SHORTLIST

Three stocks on our radar.
Intelligently selected for yours.

Three stocks worth watching, every day. Our AI connects market news, company developments and price trends to show you what deserves attention, why it matters and what to watch next.

Market coverage AI selection & review Your next research idea
RESEARCH RADARLatest selection: 2026-09-30 (ET)
01AI-SELECTED

AZN

AstraZeneca PLC

WHY IT’S ON OUR RADAR

AstraZeneca made a $2 billion investment in Summit Therapeutics, deepening its oncology pipeline and securing collaboration access without acquisition integration risk, according to Yahoo Finance.

WHAT TO WATCH

Watch for collaboration milestones and whether AZN sustains its position near the 20-session closing high (as of 2026-09-29).

What could change the view +

If the collaboration is terminated or the equity investment is unwound, the oncology catalyst would be undermined.

14-day review window · From 2026-09-30 to 2026-10-14 (calendar days)

finance.yahoo.com · 2026-09-29 Explore company research
02AI-SELECTED

MRK

Merck & Co Inc

WHY IT’S ON OUR RADAR

Merck entered an exclusive global license agreement with SciBrunch Therapeutics for oral KRAS G12D inhibitor SPR2015, with the deal potentially reaching $2.13 billion, according to Yahoo Finance.

WHAT TO WATCH

Watch for development milestones for SPR2015 and whether MRK approaches its 20-session closing high (as of 2026-09-29).

What could change the view +

If the licensed drug fails early development or the deal is terminated, the pipeline catalyst would weaken.

14-day review window · From 2026-09-30 to 2026-10-14 (calendar days)

finance.yahoo.com · 2026-09-29 Explore company research
03AI-SELECTED

SHEL

Shell PLC

WHY IT’S ON OUR RADAR

Shell approved Phase 2 of LNG Canada, doubling the Kitimat plant's export capacity to 28 million tonnes a year by the early 2030s, according to Yahoo Finance.

WHAT TO WATCH

Watch for project execution updates and whether SHEL approaches its 20-session closing high (as of 2026-09-29).

What could change the view +

If the expansion is delayed or cancelled, the capacity-growth catalyst would be undermined.

14-day review window · From 2026-09-30 to 2026-10-14 (calendar days)

finance.yahoo.com · 2026-09-29 Explore company research
01 / YOUR DAILY WORKSPACE

The big picture.
Your companies. One place.

Start with the market. Then see what matters for the companies you follow.

ThesisMemo / DashboardProduct preview
YOUR DAILY RESEARCH WORKSPACE

A clearer view of your day.

Market context Your watchlist Original evidence
Build your watchlist
01Economy & Rates

Mortgage rates jump for sixth straight week, hitting demand

Read the context +

Mortgage rates rose for a sixth consecutive week, with the 30-year fixed surging well over 7%, and mortgage demand dropped for a seventh straight week.

CNBC · Sep 30, 2026 ↗
02 / GO DEEPER

Understand the factors.
Follow the evidence.

Explore the price trend, key company developments, and the news and SEC filings behind them.

ThesisMemo / NVIDIAPublic research preview
NVDA / NVIDIA

Current key factors

Reviewed Sep 25, 2026
Open NVIDIA research
PRICE TREND · 20-SESSION LOOKBACKUpward momentum

Price rose 7.1% over the last 20 trading sessions.

Prices through Sep 24, 2026
01Potential support

Q2 FY2027 revenue $96.2B, up 106% year over year

WHAT TO WATCH

Next quarterly report for whether sequential revenue growth and the 75.0% gross margin hold.

Explore the analysis +WHAT HAPPENED

NVIDIA reported revenue of $96.2 billion for the quarter ended July 26, 2026, up 18% sequentially and 106% from a year ago, with GAAP and non-GAAP gross margins both 75.0%.

WHY IT MATTERS

Assessment: the scale of year-over-year growth shows data center AI demand remains the dominant revenue driver, though the sequential rate is far slower than the annual rate.

02Mixed impact

Supply and capacity commitments jump to $279B

WHAT TO WATCH

Whether commitments keep rising and whether management reports easing supply constraints or new inventory charges.

Explore the analysis +WHAT HAPPENED

NVIDIA states it increased supply and capacity commitments from $119 billion last quarter to $279 billion as of July 26, 2026, and that it is currently experiencing certain supply constraints while shipping both Blackwell and Rubin systems.

WHY IT MATTERS

Assessment: the large commitment increase supports planned volume but raises the cost of a demand shortfall, and management itself flags possible delays, revenue volatility and inventory provisions.

03Mixed impact

Definitive agreement to acquire Hugging Face

WHAT TO WATCH

Deal terms, regulatory review and expected closing date in later filings.

Explore the analysis +WHAT HAPPENED

On September 2, 2026, NVIDIA entered into a definitive agreement to acquire Hugging Face, Inc., which operates a platform and community for developing, sharing and deploying open-source models, datasets and applications.

WHY IT MATTERS

Assessment: the filing discloses the agreement but no price, financing or closing conditions, so the financial and competitive effect cannot yet be judged.

AI-assisted assessment · Possible influences, not proven explanations of price moves. Dates and original sources are retained.

START WITH ONE COMPANY

Explore first. Make it your workspace.

Try the free examples, save them to your watchlist, and upgrade when you want to follow more companies.

01

Explore a free example

Read NVIDIA, Palantir or AMD research. No account required.

02

Build your free watchlist

Create an account to save these three companies and return to their research.

03

Upgrade when you need more

Membership unlocks research and tracking for other covered companies.

BUILT FOR INVESTMENT RESEARCH

More than an AI answer

ThesisMemo is designed to preserve context, connect evidence, and help you reach a considered investment judgment.

GENERAL AI RESEARCHTHESISMEMO
Answers one question Maintains a living investment thesis
Starts from scratch Builds on previous research
Summarizes information Explains what changed and why it matters
Treats every company the same Understands the companies you follow and own
Produces an answer Helps you form an investment judgment
START FREE. EXPAND WHEN YOU ARE READY.

A clear place to start.
More coverage when you need it.

FREE ACCESS

Get to know the product

Read the three free company examples. Create an account when you want to save them.

  • NVIDIA, Palantir and AMD research
  • No sign-up needed to read these examples
  • A free watchlist for these three companies
  • No payment card needed to create an account
Create your free watchlist Preview a free company first ↗
THESISMEMO MEMBERSHIP

Follow more companies

Expand beyond the three free examples when you need a broader research workspace.

  • Research for other covered companies
  • Watchlist tracking across covered companies
  • Member Dashboard and market briefing
  • Discover and Calendar access
View plans See current prices and billing terms before subscribing.

Company pages show available research and its dates. Missing or pending assessments are not filled with invented content.

COMMON QUESTIONS

Good questions.
Clear answers.

What can I explore for free?

Read NVIDIA, Palantir and AMD research without signing up. Create a free account to save these three companies to your watchlist. No credit card required.

What does membership unlock?

Research and watchlist tracking for other covered companies, plus the member Dashboard, market briefings, stock shortlist history, Discover and Calendar.

View plans
How are the three stocks on your radar selected?

Our AI reviews recent news and price trends for covered companies valued at $100B or more. Each selection includes a reason, a watch point and supporting sources. This daily shortlist is separate from the three fixed free company previews.

How often does the research change?

The stock shortlist is reviewed daily, market briefings are checked hourly, and company key factors are reviewed weekly. News and SEC filings refresh periodically. Check the dates shown; earlier research stays available while updates are pending.

Which stocks can I research?

Coverage includes major US index constituents and eligible US-listed companies valued at $10B or more. Search for a stock to see the research currently available for it.

Can I check the original sources?

Yes. Company factors and market briefings link to supporting reporting or disclosures. The company timeline also links to news and SEC filings, with dates so you can follow the evidence.

Where can I explore research themes?

Open Research to explore the separate research website. The theme cards on this page take you there directly.

Explore Research
Are these personalized stock recommendations?

The same research shortlist is shown to everyone. It highlights companies to investigate, with reasons and risks to consider. It does not provide personalized buy or sell advice or promise returns.

Help us improve ThesisMemo

Allow Google Analytics to measure visits to our public pages? Your private workspace and research inputs are excluded. Privacy policy